Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1752

1.

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study.

Bassetti M, Ariyasu M, Binkowitz B, Nagata TD, Echols RM, Matsunaga Y, Toyoizumi K, Doi Y.

Infect Drug Resist. 2019 Nov 21;12:3607-3623. doi: 10.2147/IDR.S225553. eCollection 2019.

2.

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Ueda T, Yokota T, Okuzaki D, Uno Y, Mashimo T, Kubota Y, Sudo T, Ishibashi T, Shingai Y, Doi Y, Ozawa T, Nakai R, Tanimura A, Ichii M, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Stem Cell Reports. 2019 Nov 20. pii: S2213-6711(19)30405-9. doi: 10.1016/j.stemcr.2019.11.002. [Epub ahead of print]

3.

Aztreonam Combination Therapy: A Long-Awaited Answer to Metallo-β-Lactamase-Producing Gram-Negatives?

Shields R, Doi Y.

Clin Infect Dis. 2019 Dec 5. pii: ciz1159. doi: 10.1093/cid/ciz1159. [Epub ahead of print] No abstract available.

PMID:
31802110
4.

Early experience with meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae infections.

Shields RK, McCreary EK, Marini RV, Kline EG, Jones CE, Hao B, Chen L, Kreiswirth BN, Doi Y, Clancy CJ, Nguyen MH.

Clin Infect Dis. 2019 Nov 18. pii: ciz1131. doi: 10.1093/cid/ciz1131. [Epub ahead of print]

PMID:
31738396
5.

Image quality evaluation of in-treatment four-dimensional cone-beam computed tomography in volumetric-modulated arc therapy for stereotactic body radiation therapy.

Shimohigashi Y, Doi Y, Kouno Y, Yotsuji Y, Maruyama M, Kai Y, Toya R.

Phys Med. 2019 Nov 11;68:10-16. doi: 10.1016/j.ejmp.2019.11.003. [Epub ahead of print]

PMID:
31726265
6.

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.

Doi Y.

Clin Infect Dis. 2019 Nov 13;69(Supplement_7):S565-S575. doi: 10.1093/cid/ciz830.

7.

High-level carbapenem resistance triggered by ertapenem therapy in OXA-232-producing Raoultella ornithinolytica.

Iovleva A, Mettus RT, McElheny CL, Griffifth MP, Mustapha MM, Pasculle AW, Shields RK, Cooper VS, Doi Y.

Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01335-19. doi: 10.1128/AAC.01335-19. [Epub ahead of print]

PMID:
31636064
8.

Profiles of advanced hepatic fibrosis evaluated by FIB-4 index and shear wave elastography in health checkup examinees.

Yamamura S, Kawaguchi T, Nakano D, Tomiyasu Y, Yoshinaga S, Doi Y, Takahashi H, Anzai K, Eguchi Y, Torimura T, Shiba N.

Hepatol Res. 2019 Oct 21. doi: 10.1111/hepr.13436. [Epub ahead of print]

PMID:
31634983
9.

Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.

Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, Tsubakihara Y.

Sci Rep. 2019 Oct 16;9(1):14871. doi: 10.1038/s41598-019-51207-8.

10.

MRI appearance change during stereotactic radiotherapy for large brain metastases and importance of treatment plan modification during treatment period.

Kubo K, Kenjo M, Doi Y, Nakao M, Miura H, Ozawa S, Nagata Y.

Jpn J Radiol. 2019 Dec;37(12):850-859. doi: 10.1007/s11604-019-00886-4. Epub 2019 Oct 15.

11.

Pterobreathers in a model for a layered crystal with realistic potentials: Exact moving breathers in a moving frame.

Archilla JFR, Doi Y, Kimura M.

Phys Rev E. 2019 Aug;100(2-1):022206. doi: 10.1103/PhysRevE.100.022206.

PMID:
31574752
12.

Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.

Mimura K, Endo M, Takahashi A, Doi Y, Sakuragi M, Kiyokawa T, Taniguchi H, Kitabatake Y, Handa M, Tomimatsu T, Tomiyama Y, Isaka Y, Kimura T.

Int J Hematol. 2019 Sep 19. doi: 10.1007/s12185-019-02735-6. [Epub ahead of print]

PMID:
31538326
13.

Automatic gas detection in prostate cancer patients during image-guided radiation therapy using a deep convolutional neural network.

Miura H, Ozawa S, Doi Y, Nakao M, Ohnishi K, Kenjo M, Nagata Y.

Phys Med. 2019 Aug;64:24-28. doi: 10.1016/j.ejmp.2019.06.009. Epub 2019 Jun 21.

PMID:
31515026
14.

Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level.

Doi Y, Van Duin D.

Clin Infect Dis. 2019 Sep 12. pii: ciz627. doi: 10.1093/cid/ciz627. [Epub ahead of print] No abstract available.

PMID:
31513703
15.

Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.

Harada S, Aoki K, Yamamoto S, Ishii Y, Sekiya N, Kurai H, Furukawa K, Doi A, Tochitani K, Kubo K, Yamaguchi Y, Narita M, Kamiyama S, Suzuki J, Fukuchi T, Gu Y, Okinaka K, Shiiki S, Hayakawa K, Tachikawa N, Kasahara K, Nakamura T, Yokota K, Komatsu M, Takamiya M, Tateda K, Doi Y.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e01206-19. doi: 10.1128/JCM.01206-19. Print 2019 Nov.

PMID:
31434721
16.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Shahara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11;6(8). pii: ofz353. doi: 10.1093/ofid/ofz353.

17.

Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility.

Munoz-Price LS, Reeme AE, Buchan BW, Mettus RT, Mustapha MM, Van Tyne D, Shields RK, Doi Y.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00955-19. doi: 10.1128/AAC.00955-19. Print 2019 Oct.

PMID:
31332070
18.

Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature.

Babiker A, Clarke L, Doi Y, Shields RK.

Diagn Microbiol Infect Dis. 2019 Nov;95(3):114856. doi: 10.1016/j.diagmicrobio.2019.06.008. Epub 2019 Jun 24.

PMID:
31307867
19.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
20.

Severe Complications from an Unexpectedly High Serum Mycophenolic Acid Concentration in a Patient with Renal Failure Secondary to Lupus Nephritis: A Case Report.

Doi Y, Kitayama H, Yamada M, Miyama Y.

Case Rep Nephrol Dial. 2019 Jun 4;9(2):72-78. doi: 10.1159/000500516. eCollection 2019 May-Aug.

Supplemental Content

Loading ...
Support Center